Ropes & Gray: Adaptimmune Secures Up to $125M Debt Financing With Hercules Capital
May 18, 2024
May 18, 2024
BOSTON, Massachusetts, May 18 -- Ropes and Gray, a law firm, issued the following news:
Ropes & Gray advised Adaptimmune Therapeutics plc, a company redefining the treatment of solid tumor cancers with cell therapy, in a $125 million five-year, term loan facility with Hercules Capital, Inc.
The transaction strengthens the Adaptimmune's balance sheet as it executes on its sarcoma franchise with the commercial launch planned for 2026. The transaction was announced on . . .
Ropes & Gray advised Adaptimmune Therapeutics plc, a company redefining the treatment of solid tumor cancers with cell therapy, in a $125 million five-year, term loan facility with Hercules Capital, Inc.
The transaction strengthens the Adaptimmune's balance sheet as it executes on its sarcoma franchise with the commercial launch planned for 2026. The transaction was announced on . . .